Announcements Trials
Browse Landscape

Phase

Phase 3 1

Status

Completed 1

Sponsor Class

OTHER 1

Study Type

Interventional 1

Sponsor

Cancer Type

Other 1Gynecologic 1Breast 1

Conditions

Breast Neoplasms 2Vulvar Neoplasms 1Vaginal Neoplasms 1Vaginal Atrophy 1Uterine Cervical Neoplasms 1Triple Negative Breast Neoplasms 1Sexual Dysfunction, Physiological 1Fallopian Tube Neoplasms 1Endometrial Neoplasms 1Depression 1Carcinoma, Ovarian Epithelial 1Anxiety Disorders 1

Interventions

Surveys and Questionnaires 4Therapeutics 2Psilocybin 2Ketamine 2Ultraviolet Therapy 1Self-Help Groups 1Relaxation Therapy 1Psychotherapy 1Psychosocial Intervention 1Propranolol 1Oxygen 1Nitrous Oxide 1Niacin 1N-Methyl-3,4-methylenedioxyamphetamine 1Minocycline 1Midazolam 1Melatonin 1Interviews as Topic 1Imagery, Psychotherapy 1Hormones 1Exercise Test 1Early Intervention, Educational 1Donepezil 1Dehydroepiandrosterone 1Counseling 1Cognitive Behavioral Therapy 1Cannabidiol 1Autogenic Training 1Anesthesia, Local 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Has results × Anxiety Disorders × Dehydroepiandrosterone × Clear all
NCT01376349 2019-02-07

Prasterone (Dehydroepiandrosterone) in Treating Postmenopausal Cancer Survivors With Vaginal Symptoms

Alliance for Clinical Trials in Oncology

Phase 3 Completed
464 enrolled 8 charts
BreastGynecologicOther

Carcinoma, Ovarian Epithelial, Anxiety Disorders, Breast Neoplasms, Uterine Cervical Neoplasms, Depression, Fallopian Tube Neoplasms, Sexual Dysfunction, Physiological, Vaginal Neoplasms, Vulvar Neoplasms, Endometrial Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon âš¡